1-5 of 5
Small Molecule or Novel Combination Therapies
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis

Open Access
Clinical Trials & Observations
Binoy Yohannan, Matthew Rees, Morie A. Gertz, Angela Dispenzieri, Prashant Kapoor, Francis K. Buadi, David Dingli, Nelson Leung, Martha Q. Lacy, Suzanne R. Hayman, Wilson Gonsalves, Taxiarchis Kourelis, Joselle Cook, Moritz Binder, Mustaqeem Siddiqui, Yi Lin, Lisa Hwa, Michelle G. Rogers, Miriam Hobbs, Amie Fonder, Rahma Warsame, S. Vincent Rajkumar, Shaji K. Kumar, Eli Muchtar
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (2): 100092.
https://doi.org/10.1016/j.bneo.2025.100092
Published: 2025
Includes: Supplemental data
Journal Articles

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Open Access
Clinical Trials & Observations
Max J. Gordon, Sigrid Dubois, Milos D. Miljkovic, Samuel Ng, Bonita Bryant, Rahul Lakhotia, Christopher Melani, Stefania Pittaluga, Kevin Conlon, Thomas Waldmann, Louis M. Staudt, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Neoplasia
Blood Neoplasia (2024) 2 (1): 100054.
https://doi.org/10.1016/j.bneo.2024.100054
Published: 2024
Journal Articles

A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy

Free
Clinical Trials & Observations
Elizabeth A. Brem, Kevin Shieh, Dennis Juarez, Roberta Buono, Deepa Jeyakumar, Susan O’Brien, Thomas H. Taylor, David A. Fruman
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (4): 100036.
https://doi.org/10.1016/j.bneo.2024.100036
Published: 2024
Includes: Supplemental data
Journal Articles

Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium

Free
Clinical Trials & Observations
Paul G. Kemps, F. J. Sherida H. Woei-A-Jin, Patrick Schöffski, Thomas Tousseyn, Isabelle Vanden Bempt, Friederike A. G. Meyer-Wentrup, Natasja Dors, Natasha K. A. van Eijkelenburg, Marijn A. Scheijde-Vermeulen, Ingrid M. Jazet, Maarten Limper, Margot Jak, Robert M. Verdijk, Marjolein L. Donker, Nick A. de Jonge, Carel J. M. van Noesel, Konnie M. Hebeda, Suzanne van Dorp, Sanne H. Tonino, Jan A. M. van Laar, Cor van den Bos, Astrid G. S. van Halteren
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (3): 100023.
https://doi.org/10.1016/j.bneo.2024.100023
Published: 2024
Includes: Supplemental data
Journal Articles

Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial

Free
Clinical Trials & Observations
Timothy S. Pardee, Bayard L. Powell, Richard A. Larson, Joseph Maly, Michael Keng, Matthew Foster, Eun-Ji Choi, Heinz Sill, Thomas Cluzeau, Deepa Jeyakumar, Olga Frankfurt, Prapti Patel, Michael Schuster, Elisabeth Koller, Regis Costello, Uwe Platzbecker, Pau Montesinos, Susana Vives, Aziz Nazha, Rachel Cook, Carlos Vigil-Gonzales, Sylvain Chantepie, Sanjeev Luther, Jorge Cortes
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (2): 100009.
https://doi.org/10.1016/j.bneo.2024.100009
Published: 2024
Includes: Supplemental data